av/glenmark--big.svg

COM:GLENMARKPHARMA

Glenmark Pharmaceuticals

  • Stock

INR

Last Close

1,478.20

25/11 09:40

Market Cap

390.66B

Beta: -

Volume Today

654.54K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
average inventory
8.88B
-
11.01B
23.95%
14.18B
28.83%
18.53B
30.67%
20.85B
12.49%
21.41B
2.71%
21.94B
2.45%
22.06B
0.56%
23.88B
8.25%
27.39B
14.67%
27.45B
0.24%
average payables
12.00B
-
17.04B
42.00%
20.26B
18.90%
19.55B
3.51%
18.87B
3.50%
20.45B
8.41%
21.73B
6.26%
21.82B
0.39%
22.63B
3.73%
23.40B
3.40%
24.64B
5.28%
average receivables
15.10B
-
15.10B
0%
16.86B
11.65%
34.47B
104.42%
17.61B
48.92%
13.20B
-
33.51B
153.82%
40.80B
21.75%
29.79B
27.00%
book value per share
110.07
-
110.61
0.48%
152.11
37.53%
175.05
15.08%
198.08
13.15%
212.47
7.27%
215.14
1.26%
250.37
16.38%
322.03
28.62%
335.62
4.22%
278.12
17.13%
capex per share
-13.90
-
-20.06
44.39%
-31.71
58.06%
-26.53
16.35%
-37.02
39.56%
-43.85
18.43%
-33.01
24.72%
-27.46
16.82%
-28.00
1.98%
-21.53
23.11%
31.84
247.88%
capex to depreciation
-1.74
-
-2.09
20.51%
-3.31
58.00%
-1.30
60.75%
-2.95
127.24%
-2.26
23.28%
-2.23
1.37%
-1.75
21.76%
-1.62
7.06%
-0.99
38.75%
1.42
243.24%
capex to operating cash flow
-0.44
-
-1.13
156.14%
-2.58
128.47%
-1.14
55.90%
-0.63
44.33%
-0.93
47.40%
-0.67
28.41%
-0.68
2.39%
-0.71
4.06%
-0.97
36.36%
-3.38
248.26%
capex to revenue
-0.06
-
-0.08
31.26%
-0.12
42.17%
-0.08
28.83%
-0.12
38.31%
-0.13
9.14%
-0.09
29.73%
-0.07
19.96%
-0.06
9.48%
-0.05
26.41%
0.08
259.23%
cash per share
29.87
-
28.55
4.42%
31.06
8.77%
35.61
14.68%
50.06
40.57%
40.16
19.78%
41.82
4.13%
43.04
2.93%
51.15
18.85%
58.23
13.83%
58.97
1.28%
days of inventory on hand
178.07
-
235.60
32.30%
238.71
1.32%
293.53
22.96%
238.35
18.80%
241.23
1.21%
206.95
14.21%
221.98
7.26%
204.60
7.83%
239.56
17.09%
107.23
55.24%
days payables outstanding
260.09
-
379.78
46.01%
305.53
19.55%
261.21
14.51%
219.47
15.98%
237.87
8.38%
206.00
13.40%
218.17
5.91%
187.31
14.14%
192.43
2.73%
108.21
43.77%
days sales outstanding
186.10
-
164.05
-
145.00
11.61%
89.20
-
121.79
36.54%
117.56
3.47%
57.42
51.16%
debt to assets
0.38
-
0.39
3.66%
0.36
8.43%
0.39
7.68%
0.36
7.89%
0.33
8.72%
0.35
8.59%
0.32
9.52%
0.23
27.42%
0.24
2.99%
0.07
71.12%
debt to equity
1.10
-
1.27
15.65%
0.93
26.26%
0.96
2.40%
0.83
13.20%
0.74
10.61%
0.85
15.13%
0.71
17.39%
0.44
38.22%
0.49
12.02%
0.13
74.16%
dividend yield
0.00
-
0.00
27.86%
0.00
2.15%
0.00
7.24%
0.00
55.82%
0.00
16.18%
0.01
220.44%
0.01
54.48%
0.01
38.34%
0.01
40.12%
0.00
59.21%
earnings yield
0.04
-
0.02
37.04%
0.03
41.14%
0.04
21.11%
0.05
31.56%
0.05
3.47%
0.13
176.13%
0.07
44.62%
0.08
2.06%
0.02
69.99%
-0.05
339.06%
enterprise value
177.91B
-
243.62B
36.93%
254.50B
4.47%
277.11B
8.88%
188.53B
31.96%
219.42B
16.38%
98.84B
54.95%
169.60B
71.59%
150.23B
11.42%
163.02B
8.51%
272.94B
67.43%
enterprise value over ebitda
16.14
-
23.33
44.52%
17.52
24.90%
13.37
23.67%
11.03
17.50%
12.24
10.90%
5.32
56.54%
7.95
49.45%
6.03
24.18%
6.28
4.26%
24.06
283.03%
ev to operating cash flow
20.84
-
50.58
142.70%
73.80
45.92%
42.15
42.89%
11.44
72.86%
16.57
44.85%
7.10
57.16%
14.99
111.21%
13.55
9.62%
26.07
92.36%
-102.82
494.46%
ev to sales
3.00
-
3.74
24.38%
3.39
9.20%
3.13
7.83%
2.11
32.57%
2.26
7.25%
0.95
57.95%
1.57
65.10%
1.23
21.37%
1.28
3.81%
2.31
80.36%
free cash flow per share
17.60
-
-2.31
113.11%
-19.43
741.91%
-3.23
83.38%
21.38
762.38%
3.08
85.58%
16.34
429.93%
12.63
22.68%
11.29
10.64%
0.62
94.47%
-41.25
6,704.59%
free cash flow yield
0.03
-
-0.00
109.43%
-0.02
732.49%
-0.00
84.50%
0.04
1,130.99%
0.00
87.92%
0.08
1,581.44%
0.03
65.75%
0.03
6.05%
0.00
94.74%
-0.04
3,223.98%
graham net net
-77.33
-
-194.58
151.63%
-94.32
51.53%
-90.64
3.90%
-177.35
95.66%
-192.25
8.40%
-225.64
17.37%
-149.06
33.94%
-67.52
54.70%
-117.82
74.48%
-77.85
33.92%
graham number
222.60
-
208.82
6.19%
292.57
40.11%
357.57
22.22%
349.68
2.21%
388.67
11.15%
364.85
6.13%
440.08
20.62%
491.75
11.74%
281.99
42.66%
577.11
104.66%
income quality
1.23
-
0.81
33.84%
0.34
57.65%
0.52
52.00%
1.54
196.12%
1.05
31.86%
1.27
20.69%
0.82
35.59%
0.77
5.99%
0.72
6.38%
0.18
75.45%
intangibles to total assets
0.15
-
0.13
15.00%
0.14
3.12%
0.11
19.32%
0.12
6.22%
0.14
22.80%
0.15
4.33%
0.15
0.70%
0.13
10.60%
0.13
6.07%
0.09
26.04%
interest coverage
4.66
-
4.12
11.63%
6.57
59.66%
6.23
5.18%
4.70
24.53%
4.75
1.01%
3.82
19.59%
4.79
25.31%
6.73
40.60%
5.68
15.70%
1.26
77.79%
interest debt per share
127.50
-
147.09
15.37%
148.44
0.91%
175.82
18.45%
174.54
0.73%
169.52
2.88%
197.16
16.31%
189.21
4.03%
150.98
20.20%
176.31
16.78%
53.39
69.72%
inventory turnover
2.05
-
1.55
24.42%
1.53
1.31%
1.24
18.67%
1.53
23.15%
1.51
1.19%
1.76
16.56%
1.64
6.77%
1.78
8.50%
1.52
14.60%
3.40
123.40%
invested capital
1.10
-
1.27
15.65%
0.93
26.26%
0.96
2.40%
0.83
13.20%
0.74
10.61%
0.85
15.13%
0.71
17.39%
0.44
38.22%
0.49
12.02%
64.82B
13,270,461,225,289.96%
market cap
153.19B
-
213.25B
39.21%
223.19B
4.66%
240.43B
7.73%
154.47B
35.75%
184.30B
19.31%
58.08B
68.48%
131.12B
125.75%
124.72B
4.88%
131.18B
5.18%
277.21B
111.32%
net current asset value
-8.74B
-
-13.64B
56.01%
-9.23B
32.33%
-3.98B
56.85%
-4.44B
11.36%
-9.87B
122.54%
-18.11B
83.46%
-11.80B
34.86%
6.37B
154.01%
3.41B
46.44%
9.17B
168.68%
net debt to ebitda
2.24
-
2.91
29.62%
2.16
25.86%
1.77
17.88%
1.99
12.63%
1.96
1.74%
2.19
11.95%
1.80
17.78%
1.02
43.24%
1.23
19.91%
-0.38
130.70%
net income per share
20.01
-
17.52
12.42%
25.01
42.73%
32.46
29.80%
27.44
15.48%
31.60
15.17%
27.50
12.97%
34.38
25.02%
33.37
2.93%
10.53
68.45%
-53.22
605.41%
operating cash flow per share
31.50
-
17.76
43.63%
12.28
30.82%
23.30
89.67%
58.41
150.68%
46.93
19.65%
49.35
5.15%
40.09
18.76%
39.29
1.99%
22.15
43.61%
-9.41
142.46%
payables turnover
1.40
-
0.96
31.51%
1.19
24.30%
1.40
16.97%
1.66
19.02%
1.53
7.74%
1.77
15.47%
1.67
5.58%
1.95
16.47%
1.90
2.66%
3.37
77.83%
receivables turnover
1.96
-
2.22
-
2.52
13.14%
4.09
-
3.00
26.76%
3.10
3.59%
6.36
104.73%
research and ddevelopement to revenue
0.10
-
return on tangible assets
0.07
-
0.06
23.97%
0.07
29.50%
0.08
15.13%
0.07
20.12%
0.08
13.01%
0.06
18.35%
0.07
17.80%
0.06
12.96%
0.02
72.42%
-0.12
756.99%
revenue per share
218.56
-
240.42
10.00%
267.27
11.17%
314.13
17.53%
316.96
0.90%
343.95
8.51%
368.48
7.13%
382.96
3.93%
431.45
12.66%
450.80
4.49%
418.66
7.13%
roe
0.18
-
0.16
12.85%
0.16
3.79%
0.19
12.79%
0.14
25.30%
0.15
7.37%
0.13
14.05%
0.14
7.42%
0.10
24.53%
0.03
69.73%
-0.19
709.87%
roic
0.11
-
0.09
16.36%
0.10
8.04%
0.11
11.85%
0.10
14.33%
0.11
13.19%
0.09
18.27%
0.10
8.94%
0.10
7.95%
0.06
42.19%
-3.69
6,256.27%
sales general and administrative to revenue
0.02
-
0.02
30.58%
0.03
5.62%
0.03
2.64%
0.02
7.68%
0.03
22.58%
0.04
23.74%
0.03
16.38%
0.03
12.10%
0.02
27.42%
0.02
6.77%
shareholders equity per share
110.07
-
110.61
0.48%
152.11
37.53%
175.05
15.08%
198.08
13.15%
212.47
7.27%
215.14
1.26%
250.37
16.38%
322.03
28.62%
335.62
4.22%
278.14
17.13%
stock based compensation to revenue
-0.00
-
0.00
159.65%
0.00
-
0.00
98.91%
0.00
2,590.37%
0.00
147.62%
0.00
11.47%
0.00
18.13%
0.00
21.09%
tangible asset value
16.63B
-
17.29B
3.92%
27.67B
60.08%
36.06B
30.29%
40.78B
13.12%
40.47B
0.78%
38.88B
3.92%
47.29B
21.64%
71.53B
51.24%
74.05B
3.53%
65.13B
12.05%
tangible book value per share
61.38
-
63.73
3.83%
98.57
54.68%
127.78
29.63%
144.54
13.11%
143.41
0.78%
137.79
3.92%
167.61
21.64%
253.49
51.24%
262.32
3.48%
230.82
12.01%
working capital
18.14B
-
16.12B
11.11%
19.08B
18.35%
41.71B
118.61%
37.01B
11.27%
26.76B
27.70%
26.78B
0.07%
31.59B
17.96%
35.93B
13.75%
48.28B
34.38%
16.09B
66.66%

All numbers in INR (except ratios and percentages)